JP2016511767A5 - - Google Patents

Download PDF

Info

Publication number
JP2016511767A5
JP2016511767A5 JP2015558553A JP2015558553A JP2016511767A5 JP 2016511767 A5 JP2016511767 A5 JP 2016511767A5 JP 2015558553 A JP2015558553 A JP 2015558553A JP 2015558553 A JP2015558553 A JP 2015558553A JP 2016511767 A5 JP2016511767 A5 JP 2016511767A5
Authority
JP
Japan
Prior art keywords
cancer
naaladl2
pharmaceutical composition
antibody
affinity reagent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015558553A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016511767A (ja
JP6523968B2 (ja
Filing date
Publication date
Priority claimed from GBGB1303308.9A external-priority patent/GB201303308D0/en
Application filed filed Critical
Publication of JP2016511767A publication Critical patent/JP2016511767A/ja
Publication of JP2016511767A5 publication Critical patent/JP2016511767A5/ja
Application granted granted Critical
Publication of JP6523968B2 publication Critical patent/JP6523968B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015558553A 2013-02-25 2014-02-24 治療的及び診断的標的としての不活性N−アセチル化−α−結合型酸性ジペプチダーゼ−様タンパク質2(NAALADL2) Active JP6523968B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1303308.9 2013-02-25
GBGB1303308.9A GB201303308D0 (en) 2013-02-25 2013-02-25 Therapeutic and diagnostic target
PCT/GB2014/050549 WO2014128504A1 (en) 2013-02-25 2014-02-24 Inactive n-acetylated-alpha-linked acidic dipeptidase-like protein 2 (naaladl2) as a therapeutic and diagnostic target

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019033646A Division JP2019108354A (ja) 2013-02-25 2019-02-27 治療的及び診断的標的としての不活性N−アセチル化−α−結合型酸性ジペプチダーゼ−様タンパク質2(NAALADL2)

Publications (3)

Publication Number Publication Date
JP2016511767A JP2016511767A (ja) 2016-04-21
JP2016511767A5 true JP2016511767A5 (cg-RX-API-DMAC7.html) 2017-03-30
JP6523968B2 JP6523968B2 (ja) 2019-06-05

Family

ID=48092041

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015558553A Active JP6523968B2 (ja) 2013-02-25 2014-02-24 治療的及び診断的標的としての不活性N−アセチル化−α−結合型酸性ジペプチダーゼ−様タンパク質2(NAALADL2)
JP2019033646A Pending JP2019108354A (ja) 2013-02-25 2019-02-27 治療的及び診断的標的としての不活性N−アセチル化−α−結合型酸性ジペプチダーゼ−様タンパク質2(NAALADL2)

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019033646A Pending JP2019108354A (ja) 2013-02-25 2019-02-27 治療的及び診断的標的としての不活性N−アセチル化−α−結合型酸性ジペプチダーゼ−様タンパク質2(NAALADL2)

Country Status (7)

Country Link
US (1) US20160002351A1 (cg-RX-API-DMAC7.html)
EP (1) EP2958590B1 (cg-RX-API-DMAC7.html)
JP (2) JP6523968B2 (cg-RX-API-DMAC7.html)
DK (1) DK2958590T3 (cg-RX-API-DMAC7.html)
ES (1) ES2868998T3 (cg-RX-API-DMAC7.html)
GB (1) GB201303308D0 (cg-RX-API-DMAC7.html)
WO (1) WO2014128504A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014022515A1 (en) 2012-07-31 2014-02-06 Bioasis Technologies, Inc. Dephosphorylated lysosomal storage disease proteins and methods of use thereof
ES2774549T3 (es) 2013-03-13 2020-07-21 Bioasis Technologies Inc Fragmentos de P97 y usos de los mismos
US20190022244A1 (en) * 2016-01-13 2019-01-24 Bioasis Technologies, Inc. Blood-brain barrier vector compounds and conjugates thereof
CN117178341A (zh) * 2021-03-25 2023-12-05 Dh科技发展私人贸易有限公司 用于分析包括高质荷比截止值的样本的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE199392T1 (de) * 1992-12-04 2001-03-15 Medical Res Council Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung
WO2005040402A2 (en) * 2003-10-21 2005-05-06 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with n-acetylated alpha-linked acidic dipeptidase 2 (naaladase 2)
JP2010536365A (ja) * 2007-08-24 2010-12-02 オンコセラピー・サイエンス株式会社 前立腺癌の治療及び診断の標的遺伝子のための、pkib及びnaaladl2
TWI653333B (zh) * 2010-04-01 2019-03-11 安進研究(慕尼黑)有限責任公司 跨物種專一性之PSMAxCD3雙專一性單鏈抗體

Similar Documents

Publication Publication Date Title
JP2011509079A5 (cg-RX-API-DMAC7.html)
JP2016501843A5 (cg-RX-API-DMAC7.html)
JP2016513094A5 (cg-RX-API-DMAC7.html)
FI3332006T3 (fi) Uusia anti-PD-L1-vasta-aineita
JP2008538289A5 (cg-RX-API-DMAC7.html)
JP2016536330A5 (cg-RX-API-DMAC7.html)
JP2015533788A5 (cg-RX-API-DMAC7.html)
JP2017518366A5 (cg-RX-API-DMAC7.html)
RU2018112516A (ru) Метод
JP2016533395A5 (cg-RX-API-DMAC7.html)
HRP20192347T1 (hr) Antitijela prema klaudinu 18.2 koja su korisna u dijagnozi tumora
JP2012526992A (ja) Her2標的化療法に対する乳癌細胞の感受性を決定するためのバイオマーカー
SI2731972T1 (en) Anti-folate receptor alpha antibodies and uses thereof
HRP20210888T1 (hr) Vezujuće molekule specifične za cd73 i njihova upotreba
JP2013506428A5 (cg-RX-API-DMAC7.html)
JP2016539083A5 (cg-RX-API-DMAC7.html)
JP2014223083A5 (cg-RX-API-DMAC7.html)
JP2017501137A5 (cg-RX-API-DMAC7.html)
JP2013520174A5 (cg-RX-API-DMAC7.html)
JP2015531768A5 (cg-RX-API-DMAC7.html)
RU2016144178A (ru) Антитело против muc1 или его антигенсвязывающий фрагмент и его применение
JP2016511767A5 (cg-RX-API-DMAC7.html)
JP2009539082A5 (cg-RX-API-DMAC7.html)
JP2010535506A5 (cg-RX-API-DMAC7.html)
JP2016500659A5 (cg-RX-API-DMAC7.html)